Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-08 · accession 0001209191-24-003010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-08 | 2024-02-08 | VKTX | Lian Brian | Pres, CEO, Dir | S - Sale+OE | $26.87 | -269.1K | 2.26M | -11% | -$7.23M |
| DM | 2024-02-08 | 2024-02-08 | VKTX | Lian Brian | Pres, CEO, Dir | M - OptEx | $3.76 | +189.1K | 2.31M | +9% | +$711.4K |
| DM | 2024-02-08 | 2024-02-08 | VKTX | Lian Brian | Pres, CEO, Dir | M - OptEx | $0.00 | -189.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2024-02-08 | S | D | 40,000 | $28.90 | 2,184,882 | D | — | — | |
| 2 | Common | Common Stock, par value $0.00001 per share | 2024-02-08 | S | D | 40,000 | $27.45 | 2,224,882 | D | — | — | |
| 3 | Common | Common Stock, par value $0.00001 per share | 2024-02-08 | S | D | 80,000 | $26.95 | 2,264,882 | D | — | — | |
| 4 | Common | Common Stock, par value $0.00001 per share | 2024-02-08 | S | D | 60,000 | $25.95 | 2,344,882 | D | — | — | |
| 5 | Common | Common Stock, par value $0.00001 per share | 2024-02-08 | M | A | 140,000 | $4.65 | 2,404,882 | D | — | — | |
| 6 | Common | Common Stock, par value $0.00001 per share | 2024-02-08 | M | A | 49,079 | $1.23 | 2,313,961 | D | — | — | |
| 7 | Common | Common Stock, par value $0.00001 per share | 2024-02-08 | S | D | 49,079 | $25.75 | 2,264,882 | D | — | — | |
| 8 | Derivative | Stock Option (right to buy) | 2024-02-08 | M | D | 14,148 | $0.00 | 0 | D | $1.23 · 2018-01-05 to 2027-01-05 | 14,148 Common Stock | (F2) 25% of the shares subject to the option vested on each one year anniversary of the grant date. |
| 9 | Derivative | Stock Option (right to buy) | 2024-02-08 | M | D | 34,931 | $0.00 | 0 | D | $1.23 · 2017-01-05 to 2027-01-05 | 34,931 Common Stock | |
| 10 | Derivative | Stock Option (right to buy) | 2024-02-08 | M | D | 140,000 | $0.00 | 0 | D | $4.65 · 2019-01-19 to 2028-01-19 | 140,000 Common Stock | (F2) 25% of the shares subject to the option vested on each one year anniversary of the grant date. |